NEWS NOV 8
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement
Bionomics (BNOX) announced updates to its proposed re-domiciliation to the United States through a scheme of arrangement. Shareholders will receive shares in Neuphoria Therapeutics, a Delaware-incorporated company, at a revised exchange ratio: one Neuphoria common stock for every 2,160 Bionomics ordinary shares, or one for every 12 ADSs. Small Parcel Holders (fewer than 200,000 shares) can opt into a Sale Facility. The Scheme Meeting is scheduled for December 12, 2024, with the Scheme Booklet distribution expected around November 13, 2024. The Bionomics Board unanimously recommends shareholders vote in favor of the scheme.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2493Followers
107Following
27KVisitors
Follow
NoNo444 : So this means if the new company shares starts off at 1 dollar that means the value of BNOX must be 2160 per share. no way. but that may mean bnox will go higher soon? who knows..
Jaguar8 OP NoNo444 : No. 2160: 1 ratio. 2160/sh is way off.
NoNo444 Jaguar8 OP : ahhhhh so if at current price the new company shares will be $864 a share. ok so not that great
Jaguar8 OP NoNo444 : Still no.